AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases, oncology, and rare diseases.
397030 | KO
Overview
Corporate Details
- ISIN(s):
- KR7397030008
- LEI:
- Country:
- South Korea
- Address:
- 강원도 춘천시 강원대학길 1 의생명과학대학 B동 602호, 춘천시
- Website:
- http://www.aprilbio.com/en/
Description
AprilBio is a biotechnology company that develops innovative biologic drugs, including therapeutic antibodies and recombinant proteins. The company's core is its proprietary SAFA (anti-Serum Albumin Fab-Associated) platform technology, which utilizes an albumin-binding antibody fragment to create long-acting therapeutics. This platform is designed to enhance the efficacy, safety, and plasma half-life of drug candidates while minimizing adverse effects. AprilBio's research and development pipeline focuses on addressing unmet medical needs in therapeutic areas such as autoimmune diseases, oncology, and other inflammatory and rare diseases. The company advances new drug candidates through early clinical development stages for potential technology transfer.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-02-16 00:00 |
기업설명회(IR)개최
|
Korean | 6.7 KB | ||
| 2024-02-06 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.4 KB | ||
| 2024-01-22 00:00 |
전환가액의조정(제1회차)
|
Korean | 15.5 KB | ||
| 2024-01-22 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 22.9 KB | ||
| 2023-12-26 00:00 |
투자판단관련주요경영사항(안국약품, 지속형hGH, 지속형G-CSF 기술이전 계약 조기종료)
|
Korean | 6.7 KB | ||
| 2023-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.4 KB | ||
| 2023-11-29 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.4 KB | ||
| 2023-11-20 00:00 |
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 21.3 KB | ||
| 2023-11-13 00:00 |
분기보고서 (2023.09)
|
Korean | 948.5 KB | ||
| 2023-10-31 00:00 |
기타경영사항(자율공시)(신주인수권 행사)
|
Korean | 8.3 KB | ||
| 2023-10-30 00:00 |
권리락(무상증자)
|
Korean | 3.5 KB | ||
| 2023-10-23 00:00 |
전환가액의조정(제1회차)
|
Korean | 12.2 KB | ||
| 2023-10-17 00:00 |
주권매매거래정지(무상증자)
|
Korean | 4.8 KB | ||
| 2023-10-17 00:00 |
주요사항보고서(무상증자결정)
|
Korean | 9.8 KB | ||
| 2023-10-17 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 5.1 KB |
Automate Your Workflow. Get a real-time feed of all AprilBio Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for AprilBio Co.,Ltd.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for AprilBio Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
